 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Lisa Maier and Brian Day.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.988 |
|
|
|
-
Day BJ, Huang J, Barkes BQ, Gillespie M, Li L, Maier LA. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects. Lung. 2018 02; 196(1):103-114.
Score: 0.609
-
Hamzeh N, Li L, Barkes B, Huang J, Canono B, Gillespie M, Maier L, Day B. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis. Respir Med. 2016 Mar; 112:106-11.
Score: 0.135
-
Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol. 2010 Oct; 43(4):458-64.
Score: 0.088
-
Dobis DR, Sawyer RT, Gillespie MM, Huang J, Newman LS, Maier LA, Day BJ. Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease. Am J Respir Crit Care Med. 2008 May 01; 177(9):1002-11.
Score: 0.077
-
Sawyer RT, Dobis DR, Goldstein M, Velsor L, Maier LA, Fontenot AP, Silveira L, Newman LS, Day BJ. Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic Biol Med. 2005 Apr 01; 38(7):928-37.
Score: 0.064
-
Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Silveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004 Oct; 31(4):470-7.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|